A multicenter, randomized, double-blind, placebo-controlled, two-stage exploratory study to evaluate safety, tolerability, efficacy, and pharmacokinetics of intraoperative subacromial injection with 4975 [capsaicin; Adlea; Anesiva] in patients undergoing arthroscopic rotator cuff repair of the shoulder

Trial Profile

A multicenter, randomized, double-blind, placebo-controlled, two-stage exploratory study to evaluate safety, tolerability, efficacy, and pharmacokinetics of intraoperative subacromial injection with 4975 [capsaicin; Adlea; Anesiva] in patients undergoing arthroscopic rotator cuff repair of the shoulder

Discontinued
Phase of Trial: Phase II

Latest Information Update: 06 May 2009

At a glance

  • Drugs Capsaicin (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Anesiva
  • Most Recent Events

    • 12 Feb 2009 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record.
    • 17 Jul 2008 Status changed from initiated to recruiting.
    • 27 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top